Chartarlactam A shows antihyperlipidemic effects in HepG2 cells.

1528745-88-1

C23H29NO5

399.48

Chartarlactam A

(< 1 mg/ml refers to the product slightly soluble or insoluble )
Powder: -20°C for 3 years
In solvent: -80°C for 2 years